表紙
市場調査レポート

肝炎ウイルス向け診断キット:パイプライン分析

Hepatitis Viruses - Pipeline Review, 2015

発行 GlobalData 商品コード 342292
出版日 ページ情報 英文 228 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
肝炎ウイルス向け診断キット:パイプライン分析 Hepatitis Viruses - Pipeline Review, 2015
出版日: 2015年10月01日 ページ情報: 英文 228 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の、肝炎ウイルス向け診断キット (および関連製品) のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・分野別・地域別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発の動き・業界動向などを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 肝炎ウイルス診断キットの概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 肝炎ウイルス診断キット:開発中のパイプライン製品 (企業別)

  • 肝炎ウイルス診断キットの開発企業:パイプライン製品 (開発段階別)
  • 肝炎ウイルス診断キット:開発段階別のパイプライン製品の一覧

第5章 肝炎ウイルス診断キットの開発企業・製品の概要

  • Abbott Diagnostics
    • パイプライン製品および現在進行中の治験の概要
  • Access Bio, Inc.
  • Alderon Biosciences, Inc.
  • Alere Inc.
  • AXO Science S.A.S.
  • Beckman Coulter, Inc.
  • Biokit, S.A.
  • Biomagnetics Diagnostics Corporation (Inactive)
  • Bio-Rad Laboratories, Inc.
  • CeMines, Inc.
  • Cepheid
  • China Medical Technologies, Inc.
  • Co-Diagnostics HBDC, Inc.
  • Corgenix Medical Corporation
  • Da An Gene Co., Ltd.
  • Diagnostics for the Real World (Europe) Ltd.
  • DiaSorin S.p.A
  • D-Kimia, LLC.
  • Ecoli s.r.o.
  • Enzo Biochem, Inc.
  • Epistem Holdings Plc
  • Fast-track diagnostics S.a.r.l.
  • Genera Biosystems Limited
  • General Biologicals Corporation
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • InstantLabs Medical Diagnostics Corporation
  • Institut National de la Sante et de la Recherche Medicale
  • MedMira Inc.
  • Mindray Medical International Limited
  • MND Diagnostic LTD
  • NanoDiagX
  • OPKO Health, Inc.
  • Pathogenica, Inc.
  • Polartechnics Limited
  • ProteinLogic Ltd
  • Qiagen N.V.
  • Quotient Limited
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Roche Diagnostics GmbH
  • Roche Diagnostics International Ltd.
  • Sedia Biosciences Corporation
  • Siemens Healthcare Diagnostics Inc.
  • Stanford University
  • Syamala Srinivasa Life Sciences Pvt. Ltd
  • The Johns Hopkins University
  • TrovaGene, Inc.
  • University of California, Irvine
  • University of Texas Medical Branch at Galveston
  • University of Warwick
  • Vela Diagnostics
  • Xagenic Inc.
  • Xiamen Zeesan Biotech Co.,Ltd

第6章 肝炎ウイルス向け検査キット:昨今の市場動向

第7章 付録

図表一覧

目次
Product Code: GDME0075EPD

GlobalData's Medical Devices sector report, "Hepatitis Viruses - Pipeline Review, 2015" provides an overview of Hepatitis Viruses diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Viruses diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hepatitis Viruses diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hepatitis Viruses diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hepatitis Viruses diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Hepatitis Viruses Overview

3. Products under Development

  • 3.1. Hepatitis Viruses - Pipeline Products by Stage of Development
  • 3.2. Hepatitis Viruses - Pipeline Products by Territory
  • 3.3. Hepatitis Viruses - Pipeline Products by Regulatory Path
  • 3.4. Hepatitis Viruses - Pipeline Products by Estimated Approval Date
  • 3.5. Hepatitis Viruses - Ongoing Clinical Trials

4. Hepatitis Viruses - Pipeline Products under Development by Companies

  • 4.1. Hepatitis Viruses Companies - Pipeline Products by Stage of Development
  • 4.2. Hepatitis Viruses - Pipeline Products by Stage of Development

5. Hepatitis Viruses Companies and Product Overview

  • 5.1. Abbott Diagnostics Company Overview
    • 5.1.1. Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Access Bio, Inc. Company Overview
    • 5.2.1. Access Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Alderon Biosciences, Inc. Company Overview
    • 5.3.1. Alderon Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Alere Inc. Company Overview
    • 5.4.1. Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. AXO Science S.A.S. Company Overview
    • 5.5.1. AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Beckman Coulter, Inc. Company Overview
    • 5.6.1. Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Biokit, S.A. Company Overview
    • 5.7.1. Biokit, S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Biomagnetics Diagnostics Corporation (Inactive) Company Overview
    • 5.8.1. Biomagnetics Diagnostics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Bio-Rad Laboratories, Inc. Company Overview
    • 5.9.1. Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. CeMines, Inc. Company Overview
    • 5.10.1. CeMines, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Cepheid Company Overview
    • 5.11.1. Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. China Medical Technologies, Inc. Company Overview
    • 5.12.1. China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Co-Diagnostics HBDC, Inc. Company Overview
    • 5.13.1. Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Corgenix Medical Corporation Company Overview
    • 5.14.1. Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Da An Gene Co., Ltd. Company Overview
    • 5.15.1. Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Diagnostics for the Real World (Europe) Ltd. Company Overview
    • 5.16.1. Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. DiaSorin S.p.A Company Overview
    • 5.17.1. DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. D-Kimia, LLC. Company Overview
    • 5.18.1. D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Ecoli s.r.o. Company Overview
    • 5.19.1. Ecoli s.r.o. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Enzo Biochem, Inc. Company Overview
    • 5.20.1. Enzo Biochem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Epistem Holdings Plc Company Overview
    • 5.21.1. Epistem Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Fast-track diagnostics S.a.r.l. Company Overview
    • 5.22.1. Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Genera Biosystems Limited Company Overview
    • 5.23.1. Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. General Biologicals Corporation Company Overview
    • 5.24.1. General Biologicals Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. GenMark Diagnostics, Inc. Company Overview
    • 5.25.1. GenMark Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Hologic, Inc. Company Overview
    • 5.26.1. Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. InstantLabs Medical Diagnostics Corporation Company Overview
    • 5.27.1. InstantLabs Medical Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Institut National de la Sante et de la Recherche Medicale Company Overview
    • 5.28.1. Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. MedMira Inc. Company Overview
    • 5.29.1. MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Mindray Medical International Limited Company Overview
    • 5.30.1. Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. MND Diagnostic LTD Company Overview
    • 5.31.1. MND Diagnostic LTD Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. NanoDiagX Company Overview
    • 5.32.1. NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. OPKO Health, Inc. Company Overview
    • 5.33.1. OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Pathogenica, Inc. Company Overview
    • 5.34.1. Pathogenica, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Polartechnics Limited Company Overview
    • 5.35.1. Polartechnics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. ProteinLogic Ltd Company Overview
    • 5.36.1. ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Qiagen N.V. Company Overview
    • 5.37.1. Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. Quotient Limited Company Overview
    • 5.38.1. Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
    • 5.39.1. Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Roche Diagnostics GmbH Company Overview
    • 5.40.1. Roche Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. Roche Diagnostics International Ltd. Company Overview
    • 5.41.1. Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Sedia Biosciences Corporation Company Overview
    • 5.42.1. Sedia Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Siemens Healthcare Diagnostics Inc. Company Overview
    • 5.43.1. Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Stanford University Company Overview
    • 5.44.1. Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview
    • 5.45.1. Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. The Johns Hopkins University Company Overview
    • 5.46.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. TrovaGene, Inc. Company Overview
    • 5.47.1. TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. University of California, Irvine Company Overview
    • 5.48.1. University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. University of Texas Medical Branch at Galveston Company Overview
    • 5.49.1. University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. University of Warwick Company Overview
    • 5.50.1. University of Warwick Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Vela Diagnostics Company Overview
    • 5.51.1. Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Xagenic Inc. Company Overview
    • 5.52.1. Xagenic Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. Xiamen Zeesan Biotech Co.,Ltd Company Overview
    • 5.53.1. Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview

6. Hepatitis Viruses- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Hepatitis Viruses - Pipeline Products by Stage of Development
  • Table 2: Hepatitis Viruses - Pipeline Products by Territory
  • Table 3: Hepatitis Viruses - Pipeline Products by Regulatory Path
  • Table 4: Hepatitis Viruses - Pipeline Products by Estimated Approval Date
  • Table 5: Hepatitis Viruses - Ongoing Clinical Trials
  • Table 6: Hepatitis Viruses Companies - Pipeline Products by Stage of Development
  • Table 7: Hepatitis Viruses - Pipeline Products by Stage of Development
  • Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: ARCHITECT c16000 System - Anti-HAV IgG Assay - Product Status
  • Table 10: ARCHITECT c16000 System - Anti-HAV IgG Assay - Product Description
  • Table 11: ARCHITECT c16000 System - HbSAg Assay - Product Status
  • Table 12: ARCHITECT c16000 System - HbSAg Assay - Product Description
  • Table 13: ARCHITECT c4000 Integrated System - Anti-HAV IgG Assay - Product Status
  • Table 14: ARCHITECT c4000 Integrated System - Anti-HAV IgG Assay - Product Description
  • Table 15: ARCHITECT c4000 System - HbSAg Assay - Product Status
  • Table 16: ARCHITECT c4000 System - HbSAg Assay - Product Description
  • Table 17: ARCHITECT c8000 Integrated System - Anti-HAV IgG Assay - Product Status
  • Table 18: ARCHITECT c8000 Integrated System - Anti-HAV IgG Assay - Product Description
  • Table 19: ARCHITECT c8000 System - HbSAg Assay - Product Status
  • Table 20: ARCHITECT c8000 System - HbSAg Assay - Product Description
  • Table 21: ARCHITECT ci16200 Integrated System - Anti-HAV IgG Assay - Product Status
  • Table 22: ARCHITECT ci16200 Integrated System - Anti-HAV IgG Assay - Product Description
  • Table 23: ARCHITECT ci16200 Integrated System - HbSAg Assay - Product Status
  • Table 24: ARCHITECT ci16200 Integrated System - HbSAg Assay - Product Description
  • Table 25: ARCHITECT ci4100 Integrated System - Anti-HAV IgG Assay - Product Status
  • Table 26: ARCHITECT ci4100 Integrated System - Anti-HAV IgG Assay - Product Description
  • Table 27: ARCHITECT ci4100 Integrated System - HbSAg Assay - Product Status
  • Table 28: ARCHITECT ci4100 Integrated System - HbSAg Assay - Product Description
  • Table 29: ARCHITECT ci8200 Integrated System - Anti-HAV IgG Assay - Product Status
  • Table 30: ARCHITECT ci8200 Integrated System - Anti-HAV IgG Assay - Product Description
  • Table 31: ARCHITECT ci8200 Integrated System - HbSAg Assay - Product Status
  • Table 32: ARCHITECT ci8200 Integrated System - HbSAg Assay - Product Description
  • Table 33: ARCHITECT i1000SR Integrated System - Anti-HAV IgG Assay - Product Status
  • Table 34: ARCHITECT i1000SR Integrated System - Anti-HAV IgG Assay - Product Description
  • Table 35: ARCHITECT i2000SR System - Anti-HAV IgG Assay - Product Status
  • Table 36: ARCHITECT i2000SR System - Anti-HAV IgG Assay - Product Description
  • Table 37: ARCHITECT i4000SR System - Anti-HAV IgG Assay - Product Status
  • Table 38: ARCHITECT i4000SR System - Anti-HAV IgG Assay - Product Description
  • Table 39: Access Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: RosGENE For Hepatitis - Product Status
  • Table 41: RosGENE For Hepatitis - Product Description
  • Table 42: Alderon Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: eSystem - Qualitative HCV RNA Assay - Product Status
  • Table 44: eSystem - Qualitative HCV RNA Assay - Product Description
  • Table 45: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Diagnostic Test - Hepatitis B/C - Product Status
  • Table 47: Diagnostic Test - Hepatitis B/C - Product Description
  • Table 48: AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Multiplexed Detection - Anti-HCV Antibodies - Product Status
  • Table 50: Multiplexed Detection - Anti-HCV Antibodies - Product Description
  • Table 51: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: UniCel DxN - HCV Viral Load Test - Product Status
  • Table 53: UniCel DxN - HCV Viral Load Test - Product Description
  • Table 54: VERIS HBV Assay - Product Status
  • Table 55: VERIS HBV Assay - Product Description
  • Table 56: VERIS HCV Assay - Product Status
  • Table 57: VERIS HCV Assay - Product Description
  • Table 58: Biokit, S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: BIO-FLASH anti-HBe Assay - Product Status
  • Table 60: BIO-FLASH anti-HBe Assay - Product Description
  • Table 61: BIO-FLASH HAV Assay - Product Status
  • Table 62: BIO-FLASH HAV Assay - Product Description
  • Table 63: BIO-FLASH HBe Ag Assay - Product Status
  • Table 64: BIO-FLASH HBe Ag Assay - Product Description
  • Table 65: Biomagnetics Diagnostics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Diagnostic Test - Hepatitis B - Product Status
  • Table 67: Diagnostic Test - Hepatitis B - Product Description
  • Table 68: Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: BioPlex 2200 - Hepatitis Test - Product Status
  • Table 70: BioPlex 2200 - Hepatitis Test - Product Description
  • Table 71: BioPlex 2200 - HIV/Hep Screening - Product Status
  • Table 72: BioPlex 2200 - HIV/Hep Screening - Product Description
  • Table 73: CeMines, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Diagnostic Test - Hepatitis C - Product Status
  • Table 75: Diagnostic Test - Hepatitis C - Product Description
  • Table 76: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: GeneXpert Omni - Xpert HCV Viral Load - Product Status
  • Table 78: GeneXpert Omni - Xpert HCV Viral Load - Product Description
  • Table 79: Xpert HBV Viral Load Assay - Product Status
  • Table 80: Xpert HBV Viral Load Assay - Product Description
  • Table 81: Xpert HCV Quant Assay - Product Status
  • Table 82: Xpert HCV Quant Assay - Product Description
  • Table 83: China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Diagnostic Assay - HCVA - Product Status
  • Table 85: Diagnostic Assay - HCVA - Product Description
  • Table 86: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: HCV RNA Real-time PCR Kit - Product Status
  • Table 88: HCV RNA Real-time PCR Kit - Product Description
  • Table 89: Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Diagnostic Test - Hepatitis C - Product Status
  • Table 91: Diagnostic Test - Hepatitis C - Product Description
  • Table 92: Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: Real Time PCR Kit - HAV - Product Status
  • Table 94: Real Time PCR Kit - HAV - Product Description
  • Table 95: Real Time PCR Kit - HEV - Product Status
  • Table 96: Real Time PCR Kit - HEV - Product Description
  • Table 97: Real Time PCR Kit - HGV - Product Status
  • Table 98: Real Time PCR Kit - HGV - Product Description
  • Table 99: Real Time PCR Kit - HGV-LC - Product Status
  • Table 100: Real Time PCR Kit - HGV-LC - Product Description
  • Table 101: Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: SAS - Hepatitis-C Assay - Product Status
  • Table 103: SAS - Hepatitis-C Assay - Product Description
  • Table 104: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Diagnostic Assay - HBsAg High Throughput - Product Status
  • Table 106: Diagnostic Assay - HBsAg High Throughput - Product Description
  • Table 107: LIAISON XL - Hepatitis B Assay - Product Status
  • Table 108: LIAISON XL - Hepatitis B Assay - Product Description
  • Table 109: D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: HCV Nanogold Assay - Product Status
  • Table 111: HCV Nanogold Assay - Product Description
  • Table 112: Ecoli s.r.o. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: AmpliSens HBV-Eph PCR Kit - Product Status
  • Table 114: AmpliSens HBV-Eph PCR Kit - Product Description
  • Table 115: AmpliSens HBV-FEP PCR Kit - Product Status
  • Table 116: AmpliSens HBV-FEP PCR Kit - Product Description
  • Table 117: AmpliSens HBV-FRT PCR Kit - Product Status
  • Table 118: AmpliSens HBV-FRT PCR Kit - Product Description
  • Table 119: AmpliSens HBV-Monitor-FRT PCR Kit - Product Status
  • Table 120: AmpliSens HBV-Monitor-FRT PCR Kit - Product Description
  • Table 121: AmpliSens HBV/HDV-FRT PCR Kit - Product Status
  • Table 122: AmpliSens HBV/HDV-FRT PCR Kit - Product Description
  • Table 123: AmpliSens HCV-1/2/3-FEP PCR Kit - Product Status
  • Table 124: AmpliSens HCV-1/2/3-FEP PCR Kit - Product Description
  • Table 125: AmpliSens HCV-1/2/3-FRT PCR Kit - Product Status
  • Table 126: AmpliSens HCV-1/2/3-FRT PCR Kit - Product Description
  • Table 127: AmpliSens HCV-Eph PCR Kit - Product Status

List of Figures

  • Figure 1: Hepatitis Viruses - Pipeline Products by Stage of Development
  • Figure 2: Hepatitis Viruses - Pipeline Products by Territory
  • Figure 3: Hepatitis Viruses - Pipeline Products by Regulatory Path
  • Figure 4: Hepatitis Viruses - Pipeline Products by Estimated Approval Date
  • Figure 5: Hepatitis Viruses - Ongoing Clinical Trials
Back to Top